Cambrian Biopharma Stock

Cambrian is a distributed development company building therapeutics to lengthen health span.

Sign up today and learn more about Cambrian Biopharma Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Cambrian Biopharma Stock

Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.

Funding History

February 2021$60.0M
October 2021$100M


Board Member

Martin Chavez

Executive Vice President, Chemistry

Dennis Yamashita

Board Member

Paul Farr

Scientist in Residence

Daisy Robinton

Board Member

Brenton Saunders

Board Member

Steve Jurvetson

EVP, Clinical Development

Ruth Thieroff-Ekerdt

Board Member

Maryanna Saenko

Founder and CEO

James Peyer


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: